Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior...
114 insider purchases on record · latest filing 2025-11-26.
Insiders have also filed 2,103 sale transactions at EXEL.